449 related articles for article (PubMed ID: 21816833)
21. Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
Ten Hacken E; Sivina M; Kim E; O'Brien S; Wierda WG; Ferrajoli A; Estrov Z; Keating MJ; Oellerich T; Scielzo C; Ghia P; Caligaris-Cappio F; Burger JA
J Immunol; 2016 Sep; 197(6):2522-31. PubMed ID: 27534555
[TBL] [Abstract][Full Text] [Related]
22. B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia.
Mazzarello AN; Gentner-Göbel E; Dühren-von Minden M; Tarasenko TN; Nicolò A; Ferrer G; Vergani S; Liu Y; Bagnara D; Rai KR; Burger JA; McGuire PJ; Maity PC; Jumaa H; Chiorazzi N
J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 34813501
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK.
Krysov S; Steele AJ; Coelho V; Linley A; Sanchez Hidalgo M; Carter M; Potter KN; Kennedy B; Duncombe AS; Ashton-Key M; Forconi F; Stevenson FK; Packham G
Blood; 2014 Nov; 124(20):3101-9. PubMed ID: 25170122
[TBL] [Abstract][Full Text] [Related]
24. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
Seda V; Mraz M
Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
[TBL] [Abstract][Full Text] [Related]
25. The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia.
Kipps TJ
Best Pract Res Clin Haematol; 2007 Sep; 20(3):415-24. PubMed ID: 17707830
[TBL] [Abstract][Full Text] [Related]
26. Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression.
Hayakawa K; Formica AM; Brill-Dashoff J; Shinton SA; Ichikawa D; Zhou Y; Morse HC; Hardy RR
J Exp Med; 2016 Dec; 213(13):3007-3024. PubMed ID: 27899442
[TBL] [Abstract][Full Text] [Related]
27. B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.
Ntoufa S; Papakonstantinou N; Apollonio B; Gounari M; Galigalidou C; Fonte E; Anagnostopoulos A; Belessi C; Muzio M; Ghia P; Stamatopoulos K
J Immunol; 2016 May; 196(10):4410-7. PubMed ID: 27059597
[TBL] [Abstract][Full Text] [Related]
28. IL-4 enhances expression and function of surface IgM in CLL cells.
Aguilar-Hernandez MM; Blunt MD; Dobson R; Yeomans A; Thirdborough S; Larrayoz M; Smith LD; Linley A; Strefford JC; Davies A; Johnson PM; Savelyeva N; Cragg MS; Forconi F; Packham G; Stevenson FK; Steele AJ
Blood; 2016 Jun; 127(24):3015-25. PubMed ID: 27002119
[TBL] [Abstract][Full Text] [Related]
29. B-cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients.
Agathangelidis A; Chatzikonstantinou T; Stamatopoulos K
Semin Hematol; 2024 Apr; 61(2):91-99. PubMed ID: 38242773
[TBL] [Abstract][Full Text] [Related]
30. B cell receptor and antigens in CLL.
Agathangelidis A; Ntoufa S; Stamatopoulos K
Adv Exp Med Biol; 2013; 792():1-24. PubMed ID: 24014290
[TBL] [Abstract][Full Text] [Related]
31. BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies.
Robak T; Robak P
Int Rev Immunol; 2013 Aug; 32(4):358-76. PubMed ID: 23617253
[TBL] [Abstract][Full Text] [Related]
32. Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.
Feng G; Wang X
Leuk Lymphoma; 2014 Dec; 55(12):2699-705. PubMed ID: 24547708
[TBL] [Abstract][Full Text] [Related]
33. B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia.
Schmid VK; Khadour A; Ahmed N; Brandl C; Nitschke L; Rajewsky K; Jumaa H; Hobeika E
Haematologica; 2022 Aug; 107(8):1796-1814. PubMed ID: 35021605
[TBL] [Abstract][Full Text] [Related]
34. Targeting B Cell Signaling in Chronic Lymphocytic Leukemia.
Arnason JE; Brown JR
Curr Oncol Rep; 2017 Sep; 19(9):61. PubMed ID: 28755313
[TBL] [Abstract][Full Text] [Related]
35. B-cell receptor signaling in chronic lymphocytic leukemia and other B-cell malignancies.
Koehrer S; Burger JA
Clin Adv Hematol Oncol; 2016 Jan; 14(1):55-65. PubMed ID: 27057669
[TBL] [Abstract][Full Text] [Related]
36. B cell receptor signaling in chronic lymphocytic leukemia.
Burger JA; Chiorazzi N
Trends Immunol; 2013 Dec; 34(12):592-601. PubMed ID: 23928062
[TBL] [Abstract][Full Text] [Related]
37. The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia.
Packham G; Stevenson F
Semin Cancer Biol; 2010 Dec; 20(6):391-9. PubMed ID: 20816790
[TBL] [Abstract][Full Text] [Related]
38. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
[TBL] [Abstract][Full Text] [Related]
39. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
[TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen.
Kashuba E; Eagle GL; Bailey J; Evans P; Welham KJ; Allsup D; Cawkwell L
J Proteomics; 2013 Oct; 91():478-85. PubMed ID: 23938224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
